Microsoft stock rises as Wall Street refocuses on AI deals and next week’s earnings
Microsoft shares rose 1.6% to close near $451.22 in after-hours trading Thursday, outpacing other tech giants. The move followed news of a Bristol Myers partnership to use Microsoft’s AI radiology platform for early lung cancer detection. Investors are awaiting Microsoft’s fiscal Q2 earnings, due Jan. 28.